Holen Sie sich die Stockscreener-App
6.42
0.00%
0.00
Handel nachbörslich:
6.42
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
Trend Recap: Can Fennec Pharmaceuticals Inc sustain earnings growth2026 Short Interest & Step-by-Step Swing Trade Plans - baoquankhu1.vn
(FENC) Risk Channels and Responsive Allocation - Stock Traders Daily
FENC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Adherex Technologies (NASDAQ:FENC) Cut to Hold at Wall Street Zen - MarketBeat
Adherex Technologies (NASDAQ:FENC) Director Rosty Raykov Sells 10,946 Shares - MarketBeat
[Form 4] FENNEC PHARMACEUTICALS INC. Insider Trading Activity - Stock Titan
Fennec (FENC) CEO gets 200,000 options and new common shares - Stock Titan
FENNEC (FENC) director exercises 15,598 options and sells shares under 10b5-1 plan - Stock Titan
CMO at Fennec (NASDAQ: FENC) receives 120,000 stock options award - Stock Titan
Fennec (NASDAQ: FENC) CCO gets 120,000 options, 20,679 shares - Stock Titan
Public market insider net buying at Fennec Pharmaceuticals (FRX) - The Globe and Mail
FRX.CA Forecast, Price Target & Analyst Ratings | FENNEC PHARMACEUTICALS INC (TSX:FRX) - ChartMill
FENC (NASDAQ) insider sale notice: 10,946 shares via option exercise - Stock Titan
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
HC Wainwright Has Bearish Forecast for FENC Q1 Earnings - MarketBeat
Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
FENC Stock Price, Quote & Chart | FENNEC PHARMACEUTICALS INC (NASDAQ:FENC) - ChartMill
Aug Ideas: Does Fennec Pharmaceuticals Inc have a competitive edge2026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
Fennec Pharmaceuticals earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
CEO Moves: Can Fennec Pharmaceuticals Inc expand its profit marginsWeekly Trade Analysis & Risk Controlled Daily Plans - baoquankhu1.vn
HC Wainwright Issues Negative Forecast for FENC Earnings - MarketBeat
24 new Fennec hires get options at $5.77 under Nasdaq rule - Stock Titan
Can Fennec Pharmaceuticals Inc stock double in the next yearStock Surge & Accurate Intraday Trade Tips - baoquankhu1.vn
Income Plays: Does Fennec Pharmaceuticals Inc have a sustainable dividend2026 Fed Impact & High Return Stock Watch Alerts - baoquankhu1.vn
Fennec Pharmaceuticals 2025 Annual Report: PEDMARK® Commercialization, Risks, and Intellectual Property Overview - Minichart
Adherex Technologies (NASDAQ:FENC) Cut to Strong Sell at Zacks Research - Defense World
Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds - TipRanks
Fennec Pharmaceuticals 2025 10-K: Revenue $44.6M, Net Loss $(9.7)M - TradingView
Fennec (NASDAQ: FENC) expands PEDMARK reach and delays generic entry - stocktitan.net
Adherex Technologies (NASDAQ:FENC) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Fennec (NASDAQ: FENC) CFO exercises 13,072 stock options in Form 4 - Stock Titan
Fennec (NASDAQ: FENC) Chief Strategy Officer exercises options, holds 145,300 shares - Stock Titan
Fennec Pharmaceuticals (FENC) Quarterly Loss Near Breakeven Challenges Bearish Profitability Narratives - Sahm
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript - Insider Monkey
Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Can Afford To Invest In Growth - Yahoo Finance
Fennec Pharmaceuticals Hits Day Low of CAD 8.26 Amid Price Pressure - Markets Mojo
Fennec Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Day Trade: Will Fennec Pharmaceuticals Inc benefit from AI trendsEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Adherex Technologies (FENC) to Release Earnings on Wednesday - MarketBeat
Fennec Pharmaceuticals Reports Record 2025 PEDMARK® Sales Growth and Financial Results, Highlights Pipeline and Global Expansion - Minichart
(FENC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Fennec Pharmaceuticals Reports Record FY2025 Net Product Sales of $44.6M, Q4 Sales $13.8M - TradingView
Record PEDMARK growth but wider 2025 loss for Fennec (NASDAQ: FENC) - stocktitan.net
Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... By GuruFocus - Investing.com Canada
Fennec Pharmaceuticals misses Q4 estimates on earnings and revenue - MSN
Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates - AlphaStreet
Adherex Technologies Q4 2025 Earnings Call Transcript - MarketBeat
Earnings Call Summary | Fennec Pharmaceuticals(FENC.US) Q4 2025 Earnings Conference - Moomoo
Adherex Technologies Q4 Earnings Call Highlights - MarketBeat
Adherex Technologies (NASDAQ:FENC) Issues Quarterly Earnings Results, Misses Expectations By $0.20 EPS - marketbeat.com
Earnings call transcript: Fennec Pharmaceuticals Q4 2025 misses expectations - Investing.com
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating - Moomoo
Fennec Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fennec Pharmaceuticals posts fiscal year 2025 financial results and business update - Traders Union
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Fennec Pharmaceuticals (NASDAQ:FENC) Reports Q4 2025 Revenue Growth but Misses Earnings Estimates - chartmill.com
Fennec Pharmaceuticals Posts Record PEDMARK Sales and Broadens Clinical Footprint in 2025 - TipRanks
FENNEC PHARMACEUTICALS ($FENC) Releases Q4 2025 Earnings - Quiver Quantitative
Fennec Pharmaceuticals misses Q4 estimates on earnings, revenue By Investing.com - Investing.com Australia
Fennec Pharmaceuticals misses Q4 estimates on earnings, revenue - Investing.com UK
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - manilatimes.net
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):